Patent details

EP3986890 Title: BENZISOXAZOLE SULFONAMIDE DERIVATIVES

Basic Information

Publication number:
EP3986890
PCT Application Number:
IB2020055589
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207437732
PCT Publication Number:
WO2020254946
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BENZISOXAZOLE SULFONAMIDE DERIVATIVES
French Title of Invention:
DÉRIVÉS DE BENZISOXAZOLE SULFONAMIDE
German Title of Invention:
BENZISOXAZOL-SULFONAMID-DERIVATE
SPC Number:

Dates

Filing date:
16/06/2020
Grant date:
15/11/2023
EP Publication Date:
27/04/2022
PCT Publication Date:
24/12/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/11/2023
EP B1 Publication Date:
15/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/06/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/11/2023
 
 

Name:
CTXT PTY LTD
Address:
305 Grattan Street Parkville, Melbourne, VIC 3000, Australia (AU)

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
16/11/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CAMERINO, Michelle Ang
Address:
Australia (AU)

2

Name:
KUNG, Pei-Pei
Address:
United States (US)

3

Name:
KUMPF, Robert Arnold
Address:
United States (US)

4

Name:
SUTTON, Scott Channing
Address:
United States (US)

5

Name:
GREASLEY, Samantha Elizabeth
Address:
United States (US)

6

Name:
RICHARDSON, Paul Francis
Address:
United States (US)

7

Name:
BRODSKY, Oleg
Address:
United States (US)

8

Name:
HOFFMAN, Robert Louis
Address:
United States (US)

9

Name:
STUPPLE, Paul Anthony
Address:
Australia (AU)

10

Name:
BOZIKIS, Ylva Elisabet Bergman
Address:
Australia (AU)

Priority

1

Priority Number:
201962863199 P
Priority Date:
18/06/2019
Priority Country:
United States (US)

2

Priority Number:
201962953223 P
Priority Date:
24/12/2019
Priority Country:
United States (US)

3

Priority Number:
202063025278 P
Priority Date:
15/05/2020
Priority Country:
United States (US)

Classification

IPC classification:
C07D 413/06; A61K 31/41; A61K 31/4192; A61K 31/4402; A61K 31/497; A61K 31/506; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202346
Publication date:
15/11/2023
Description:
Grant (B1)

2

Issue number:
202347
Publication date:
22/11/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202516
Publication date:
16/04/2025
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
30/06/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2025
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
66 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
16/11/2023 Power Of Attorney 1
23/11/2023 Outgoing Correspondence 1